One School District. 23,000 Insurance Claims. A 92% Drop in Inpatient Admissions.
A large Louisiana school district gave its employees two health plan options in 2018: one that included a direct primary care provider, one that didn’t. An analytics firm spent a year tracking what happened to the claims.
The group with DPC had 92.7% fewer inpatient admissions.
That number demands context, which I’ll get to. But it’s not the only number worth looking at.
What the Study Found
KPI Ninja, a healthcare analytics company, analyzed 23,593 insurance claims from the district’s 2018-2019 plan year using the Johns Hopkins ACG risk-scoring system. The study compared a PPO Direct plan that included Nextera Healthcare as a DPC provider against a PPO Choice plan that didn’t.
Compared to the traditional PPO group, the DPC group showed:
- 92.7% fewer inpatient admissions
- 76.7% fewer outpatient hospital visits
- 40.6% fewer urgent care visits
- 9.6% fewer emergency room visits
On cost, the DPC plan ran $76 per member per month less than the comparison plan. Over a full year, that gap came to $913 per member.
The Caveats Are Real
The 92.7% inpatient reduction is the kind of number that makes people skeptical, and the skepticism is reasonable.
School district employees are a specific population. Younger, employed, generally healthier than a Medicare population. When you start from a low baseline of hospitalizations, even a difference of a few events between groups can produce large percentage swings. Without knowing the raw hospitalization counts behind that 92.7%, the number tells you direction more than magnitude.
The study was also published by Nextera Healthcare, the DPC provider in the analysis. That doesn’t make the numbers wrong. It means they haven’t been independently replicated in larger peer-reviewed research.
Medscape published a clinical analysis this week asking whether DPC can reduce hospital admissions and readmissions. When a publication with millions of physician readers puts that question in front of its audience, the model has moved into a different conversation than it was having five years ago. Researchers have noted that most available DPC outcomes evidence comes from employer-sponsored populations and observational designs, not randomized trials. That’s an honest description of where the field stands.
Why the Mechanism Makes Sense Anyway
You don’t need the employer study to explain why smaller panels might produce fewer hospitalizations.
DPC physicians carry 400 to 800 patients on average, versus 2,000 to 2,500 in traditional fee-for-service primary care. That ratio determines whether a patient can reach their doctor before a worsening condition becomes a hospitalization.
A patient managing hypertension or diabetes in a DPC practice can often get a same-day appointment or at least a same-day conversation. When a problem is still manageable at the outpatient level, that access changes the outcome. In a traditional practice, a two-week wait can turn an office visit into an emergency room trip.
Post-discharge follow-up is another piece. When a DPC patient leaves the hospital, a follow-up within 24 to 48 hours is achievable. That window matters. Hospital readmission rates track closely with whether patients get early follow-up after discharge. Most traditionally-insured patients don’t.
The mechanism isn’t speculative. The evidence base is just still thin.
What This Means
If you’re pitching DPC to a self-funded employer, the Nextera data is worth knowing. A $913 per member per year cost difference and a 40% reduction in urgent care visits are numbers a benefits committee can follow. Pair them with the Hint Health patient experience benchmark, which showed an 89% PCPCM quality score and an 85 Net Promoter Score across 12 DPC practices, and you have a business case that holds up under scrutiny.
If you’re a physician weighing the DPC model, the hospital utilization data adds a clinical dimension to the usual business argument. You might not just be offering convenience. You might actually be keeping patients out of the hospital.
The Medscape clinical coverage of this question is the signal that matters most this week. The data is early. It comes from a specific employer population in a specific setting. But the direction is consistent, and the mainstream clinical community is starting to ask for the evidence. That’s a shift worth tracking.